ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,850Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 1111

$789K Total Retail Price of All Prescriptions

Rank: 79 out of 1111

681 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 681 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 681 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 14,002 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 880 743 1 2
OMEPRAZOLE 766 675 2 4
LEVOTHYROXINE SODIUM 636 526 3 3
HYDROCODONE-ACETAMINOPHEN 582 415 S3 4 1
TRAMADOL HCL 530 430 5 13
CITALOPRAM HBR 514 460 6 14
METOPROLOL TARTRATE 465 431 7 12
FUROSEMIDE 419 356 8 6
AMLODIPINE BESYLATE 355 344 9 7
GABAPENTIN 345 288 10 10
PRAVASTATIN SODIUM 323 263 11 17
METFORMIN HCL 319 276 12 8
RANITIDINE HCL 296 231 13 29
POTASSIUM CHLORIDE 294 246 14 9
HYDROCHLOROTHIAZIDE 272 221 15 11
ZOLPIDEM TARTRATE 262 200 16 16
MELOXICAM 258 175 17 18
LOVASTATIN 214 202 18 41
ALENDRONATE SODIUM 202 179 19 35
WARFARIN SODIUM 200 132 20 19
PROAIR HFA 189 139 21 38
SIMVASTATIN 176 152 22 5
FLUTICASONE PROPIONATE 165 139 23 27
ATENOLOL 159 135 24 22
NAPROXEN 151 120 25 85
GLIPIZIDE 147 135 26 57
PREDNISONE 146 123 27 48
DOXAZOSIN MESYLATE 143 140 28 87
MORPHINE SULFATE ER 139 93 S2 29 74
FLUOXETINE HCL 138 106 30 44
PAROXETINE HCL 125 93 31 55
NAMENDA 125 124 31 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 89 33 23
DIOVAN 111 111 34 51
CIPROFLOXACIN HCL 106 95 35 58
VENTOLIN HFA 105 69 36 122
MORPHINE SULFATE 105 71 S2 36 190
CARVEDILOL 105 96 36 21
ATORVASTATIN CALCIUM 100 99 39 15
AMITRIPTYLINE HCL 98 86 R 40 64
ADVAIR DISKUS 96 95 41 43
METOPROLOL SUCCINATE 96 79 41 20
TRAZODONE HCL 91 60 43 32
DONEPEZIL HCL 91 86 43 25
CYCLOBENZAPRINE HCL 91 73 R 43 37
DILTIAZEM ER 89 85 46 158
OXYBUTYNIN CHLORIDE 88 83 47 110
SPIRIVA 84 59 48 53
VERAPAMIL ER 80 78 49 100
DILTIAZEM 24HR CD 80 72 49 152
DIGOXIN 77 73 51 47
AMLODIPINE BESYLATE-BENAZEPRIL 76 76 52 67
POLYETHYLENE GLYCOL 3350 75 58 53 45
CARISOPRODOL 74 52 R 54 54
TRIAMTERENE-HCTZ 71 60 55 80
PREMARIN 68 55 R 56 90
ISOSORBIDE MONONITRATE ER 67 66 57 73
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 47 57 71
ESTRADIOL 64 49 R 59 102
RISPERIDONE 64 64 59 60
GEMFIBROZIL 63 59 61 92
DIVALPROEX SODIUM 63 51 61 82
CYMBALTA 62 35 63 40
BUSPIRONE HCL 59 52 64 96
BUPROPION HCL SR 56 32 65 150
SYNTHROID 55 55 66 63
AMIODARONE HCL 55 46 66 145
PROMETHAZINE HCL 54 39 R 68 69
CLOPIDOGREL 53 49 69 30
ENALAPRIL MALEATE 53 49 69 56
EXELON 53 53 69 121
COMBIVENT 52 48 72 129
OXYCONTIN 50 38 S2 73 106
ALLOPURINOL 50 50 73 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.